PQE groupan international life sciences consulting company, launched global quality cannabisa start-up dedicated to supporting pharmaceutical companies in all aspects of medical cannabis development and distribution.
mechanical engineering, GxP Quality Compliance, Regulatory Affairs, medical-scientific advice, clinical studies and a GQC Academy: These are the main services that GQC will provide to customers through the knowledge acquired in more than two decades by PQE Group.
“This new project represents an important challenge for me. I strongly believe in the therapeutic power of cannabis in the medical world,” he said Gilda D’Incerti, CEO of PQE Group, Founder and President of GQC. “I wanted to support the research, development and dissemination of medicinal cannabis by creating this new start-up. I have personally and with great care researched the professionals who make up the new GQC team: chemists, pharmacists, medics and biologists who take care of the supply chain at three hundred and sixty degrees.”
However, the market is still struggling with fragmented and sometimes opaque national legislation. This is exactly where the innovative offer from GQC comes in, which will apply the highest international standards on site in order to always guarantee the end patient effectiveness, safety and quality.
“I believe medicinal cannabis should be treated the same as any other pharmaceutical product. Our vision is to support the development of new therapies through effective data quality management by accelerating the registration of cannabis products and making the supply chain timing faster for patients,” Riccardo SalvagniniVice President of GQC, during the startup’s launch ceremony.
Photo of Esteban Lopez on Unsplash
